Published in JAMA on March 16, 1990
The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. Am J Public Health (1996) 9.20
HIV infection among Quebec women giving birth to live infants. CMAJ (1990) 3.38
Economic impact of HIV infection and coronary heart disease in immigrants to Canada. CMAJ (1992) 2.34
Women and HIV infection and AIDS in Canada: should we worry? CMAJ (1990) 2.19
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol (1992) 1.85
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J Virol (1992) 1.80
Prospective memory deficits are associated with unemployment in persons living with HIV infection. Rehabil Psychol (2011) 1.13
Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J Exp Med (1993) 1.08
A method for identifying persons at high risk for sexually transmitted infections: opportunity for targeting intervention. Am J Public Health (1993) 1.06
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. J Virol (1994) 1.04
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin Microbiol Rev (1996) 1.02
AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease. Proc Natl Acad Sci U S A (1991) 0.98
Projecting the incidence of AIDS. JAMA (1990) 0.93
A new approach to estimating AIDS incubation times: results in homosexual infected men. J Epidemiol Community Health (1992) 0.83
Human immunodeficiency virus (HIV) infection epidemic: medical and social issues and the unresolved dilemmas. J Natl Med Assoc (1993) 0.82
Decline in human immunodeficiency virus seropositivity and seroconversion in US Navy enlisted personnel: 1986 to 1989. Navy HIV Working Group. Am J Public Health (1992) 0.80
Role of avidity and breadth of the CD4 T cell response in progression to AIDS. Proc Biol Sci (2006) 0.79
Recent advances in the medical management of early HIV disease. J Gen Intern Med (1991) 0.75
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1997) 18.10
Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med (1994) 13.11
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med (1999) 12.68
Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med (1993) 8.49
Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study. JAMA (1987) 7.24
The San Francisco Men's Health Study: III. Reduction in human immunodeficiency virus transmission among homosexual/bisexual men, 1982-86. Am J Public Health (1987) 5.78
Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA (1989) 5.66
HIV infection in homosexual and bisexual men 18 to 29 years of age: the San Francisco Young Men's Health Study. Am J Public Health (1994) 5.18
Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health (1987) 5.06
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions. Ann Intern Med (1999) 5.05
Reported changes in the sexual behavior of men at risk for AIDS, San Francisco, 1982-84--the AIDS Behavioral Research Project. Public Health Rep (1986) 4.93
The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med (1995) 4.60
Male-to-female transmission of human immunodeficiency virus. JAMA (1987) 4.52
Active case finding of tuberculosis: historical perspective and future prospects. Int J Tuberc Lung Dis (2005) 4.36
Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA (2000) 4.36
Impact of anti-vaccine movements on pertussis control: the untold story. Lancet (1998) 4.18
Tuberculosis in patients with the acquired immunodeficiency syndrome. Clinical features, response to therapy, and survival. Am Rev Respir Dis (1987) 4.11
Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med (1994) 4.04
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) (1988) 4.03
Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest (2000) 3.96
HIV and tuberculosis infection in San Francisco's homeless adults. Prevalence and risk factors in a representative sample. JAMA (1994) 3.80
Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles. JAMA (1999) 3.77
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection. J Acquir Immune Defic Syndr (2001) 3.67
Zidovudine and the natural history of the acquired immunodeficiency syndrome. N Engl J Med (1991) 3.64
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis (1992) 3.61
Routine prenatal screening for HIV infection. Lancet (1991) 3.43
Long-term HIV-1 infection without immunologic progression. AIDS (1994) 3.41
Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection. Lancet (1998) 3.37
A molecular epidemiologic analysis of tuberculosis trends in San Francisco, 1991-1997. Ann Intern Med (1999) 3.26
Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy. JAMA (1998) 3.07
Herpes zoster and human immunodeficiency virus infection. J Infect Dis (1992) 3.04
Delayed tuberculosis diagnosis and tuberculosis transmission. Int J Tuberc Lung Dis (2006) 2.97
Does influenza vaccination prevent asthma exacerbations in children? J Pediatr (2001) 2.89
Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet (1992) 2.79
Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chronic Dis (1974) 2.78
Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med (1991) 2.77
Life-style and future health: evidence from the Alameda County study. Prev Med (1980) 2.74
Prevalence, incidence, and progression of human immunodeficiency virus infection in homosexual and bisexual men in hepatitis B vaccine trials, 1978-1988. Am J Epidemiol (1989) 2.74
Natural history of HIV infection in the era of combination antiretroviral therapy. AIDS (1999) 2.73
The San Francisco Men's Health Study: continued decline in HIV seroconversion rates among homosexual/bisexual men. Am J Public Health (1988) 2.69
Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr (1989) 2.65
Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa. AIDS Res Hum Retroviruses (2004) 2.64
Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol (1987) 2.62
Protease inhibitors in the homeless. JAMA (1997) 2.57
Use of T lymphocyte subset analysis in the case definition for AIDS. J Acquir Immune Defic Syndr (1993) 2.57
Risk factors for injuries from in-line skating and the effectiveness of safety gear. N Engl J Med (1996) 2.56
Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis. Antimicrob Agents Chemother (1999) 2.54
Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco. Hepatology (2001) 2.54
Differences in contributing factors to tuberculosis incidence in U.S. -born and foreign-born persons. Am J Respir Crit Care Med (1998) 2.52
The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med (1998) 2.46
Antibody responses to Haemophilus influenzae type B vaccines in men with human immunodeficiency virus infection. N Engl J Med (1991) 2.46
Errors in the treatment of tuberculosis in Baltimore. Chest (2000) 2.46
Clinical, immunologic, and serologic findings in men at risk for acquired immunodeficiency syndrome. The San Francisco Men's Health Study. JAMA (1987) 2.43
Impact of empiric antibiotics and chest radiograph on delays in the diagnosis of tuberculosis. Int J Tuberc Lung Dis (2005) 2.40
The relationship of air pollution and economic status to total mortality and selected respiratory system mortality in men. I. suspended particulates. Arch Environ Health (1967) 2.39
Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis (1987) 2.32
Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 2.29
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. N Engl J Med (1990) 2.29
Eleven years of community-based directly observed therapy for tuberculosis. JAMA (1995) 2.27
Incubation period of AIDS in San Francisco. Nature (1989) 2.26
Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy. JAMA (2000) 2.25
Survival trends for patients with AIDS. JAMA (1990) 2.24
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis (1993) 2.21
Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis (1999) 2.18
Latent tuberculosis infection among undergraduate medical students in Rio de Janeiro State, Brazil. Int J Tuberc Lung Dis (2005) 2.16
Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis. Am J Respir Crit Care Med (1996) 2.14
Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med (1991) 2.12
Safety of revaccination with pneumococcal polysaccharide vaccine. JAMA (1999) 2.09
AIDS and intravenous drug use: the real heterosexual epidemic. Br Med J (Clin Res Ed) (1987) 2.08
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. JAMA (1991) 2.08
Natural history of disseminated Mycobacterium avium complex infection in AIDS. J Infect Dis (1991) 2.07
Confounding in studies of adverse reactions to vaccines. Am J Epidemiol (1992) 2.06
Hypernatremia in elderly patients. A heterogeneous, morbid, and iatrogenic entity. Ann Intern Med (1987) 2.06
Incidence of salmonellosis in patients with AIDS. J Infect Dis (1987) 2.04
Mycobacteria and AIDS mortality. Am Rev Respir Dis (1989) 2.02
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis (1995) 2.01
The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels. AIDS (1993) 2.00
Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Ann Epidemiol (1996) 1.97
Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol (1986) 1.97
Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin Infect Dis (1998) 1.97
Risk of developing AIDS in HIV-infected cohorts of hemophilic and homosexual men. JAMA (1989) 1.96
Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med (1996) 1.92
Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors. Int J Tuberc Lung Dis (2006) 1.91
Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.89
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy. AIDS (2001) 1.88
Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med (1994) 1.87
Kaposi's sarcoma in a cohort of homosexual and bisexual men. Epidemiology and analysis for cofactors. Am J Epidemiol (1990) 1.87
The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med (2001) 1.84